Cetera Advisor Networks LLC Teva Pharmaceutical Industries LTD Transaction History

Cetera Advisor Networks LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $226,662 - $306,536	21,243 New	21,243 $299,000
Q2 2023 Aug 09, 2023	BUY	$7.2 - $9.47 $180,568 - $237,498	25,079 New	25,079 $188,000
Q3 2021 Nov 16, 2021	SELL	$8.38 - $10.18 $93,780 - $113,924	-11,191 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$9.9 - $11.56 $1,613 - $1,884	-163 Reduced 1.44%	11,191 $111,000
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $1,240 - $1,537	-120 Reduced 1.05%	11,354 $131,000
Q4 2020 Feb 17, 2021	SELL	$8.61 - $11.04 $6,491 - $8,324	-754 Reduced 6.17%	11,474 $111,000
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $8,561 - $12,677	-999 Reduced 7.55%	12,228 $110,000
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $19,983 - $32,288	2,461 Added 22.86%	13,227 $163,000
Q1 2020 May 08, 2020	BUY	$6.69 - $13.45 $72,024 - $144,802	10,766 New	10,766 $97,000
Q3 2019 Nov 06, 2019	SELL	$6.16 - $9.6 $69,109 - $107,702	-11,219 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$8.12 - $15.72 $4,977 - $9,636	613 Added 5.78%	11,219 $102,000
Q1 2019 May 06, 2019	SELL	$15.58 - $20.01 $4,455 - $5,722	-286 Reduced 2.63%	10,606 $166,000
Q4 2018 Feb 15, 2019	BUY	$14.59 - $23.84 $15,392 - $25,151	1,055 Added 10.72%	10,892 $170,000
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $207,167 - $252,319	9,837 New	9,837 $209,000
Q4 2017 Feb 08, 2018	SELL	$11.23 - $19.1 $122,261 - $207,941	-10,887 Closed	0 $0
Q3 2017 Nov 16, 2017	SELL	$15.41 - $32.17 $29,540 - $61,669	-1,917 Reduced 14.97%	10,887 $195,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,804	12,804 $423,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.